NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $681,005 | -0.4% | 6,658 | -1.8% | 0.81% | +0.5% |
| Q2 2023 | $683,717 | -2.6% | 6,778 | -11.2% | 0.80% | -9.8% |
| Q1 2023 | $701,911 | -3.3% | 7,632 | -4.6% | 0.89% | +8.0% |
| Q4 2022 | $725,903 | +20.6% | 8,002 | +1.0% | 0.82% | +15.1% |
| Q3 2022 | $602,000 | -20.8% | 7,926 | -11.9% | 0.72% | -14.8% |
| Q2 2022 | $760,000 | -1.9% | 9,000 | +1.8% | 0.84% | +9.4% |
| Q1 2022 | $775,000 | +5.9% | 8,837 | +5.6% | 0.77% | +2.8% |
| Q4 2021 | $732,000 | +7.3% | 8,369 | +0.3% | 0.75% | -7.1% |
| Q3 2021 | $682,000 | -10.3% | 8,347 | +0.1% | 0.81% | -14.3% |
| Q2 2021 | $760,000 | +7.3% | 8,338 | +0.6% | 0.94% | +4.4% |
| Q1 2021 | $708,000 | -48.3% | 8,286 | -42.9% | 0.90% | -6.1% |
| Q4 2020 | $1,370,000 | +4.3% | 14,504 | -4.0% | 0.96% | -3.0% |
| Q3 2020 | $1,313,000 | -1.7% | 15,103 | -1.2% | 0.99% | -10.3% |
| Q2 2020 | $1,336,000 | – | 15,292 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |